Frontline Venetoclax (ven) Based Combination Therapy in Older Adults with Acute Myeloid Leukemia Treated in the Real-World Setting; A MultiInstitutional Retrospective Study

被引：2
|
作者：
Patel, Prapti A. [1 ]
Madanat, Yazan F. [2 ]
Belli, Andrew J. [3 ]
Hansen, Eric [4 ]
Foss, Heidi [4 ]
Schulte, Molly [4 ]
Wang, Ching-Kun [4 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Med Oncol, Dallas, TX USA
[2] UT Southwestern Med Ctr, Simmons Comprehens Canc Ctr, Dallas, TX USA
[3] COTA Inc, New York, NY USA
[4] COTA Inc, Boston, MA USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-153186
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4136
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Outcomes of Adults Treated with a Hypomethylating Agent Plus Venetoclax for Relapsed/Refractory Acute Myeloid Leukemia: A Multicenter Retrospective Study
    Geramita, Emily
    Wang, Hong
    Bastacky, Melissa
    Cohen, Jessica
    Shallis, Rory Michael
    Badar, Talha
    Litzow, Mark R.
    Im, Annie
    BLOOD, 2022, 140 : 6187 - 6188
  • [42] Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation: A Cohort Study in the Real-World Setting of a Tertiary Center
    Goker, Hakan
    Cinar, Olgu Erkin
    Demiroglu, Haluk
    Malkan, Uemit Yavuz
    Karakulak, Elifcan Aladag
    Buyukasik, Yahya
    TURKISH JOURNAL OF HEMATOLOGY, 2023, 40 (03) : 213 - 215
  • [43] Myelomonocytic and monocytic acute myeloid leukemia demonstrate comparable poor outcomes with venetoclax-based treatment: a monocentric real-world study
    Lei Zhao
    Jinjun Yang
    Mengran Chen
    Xinrong Xiang
    Hongbing Ma
    Ting Niu
    Yuping Gong
    Xinchuan Chen
    Jiazhuo Liu
    Yu Wu
    Annals of Hematology, 2024, 103 : 1197 - 1209
  • [44] Myelomonocytic and monocytic acute myeloid leukemia demonstrate comparable poor outcomes with venetoclax-based treatment: a monocentric real-world study
    Zhao, Lei
    Yang, Jinjun
    Chen, Mengran
    Xiang, Xinrong
    Ma, Hongbing
    Niu, Ting
    Gong, Yuping
    Chen, Xinchuan
    Liu, Jiazhuo
    Wu, Yu
    ANNALS OF HEMATOLOGY, 2024, 103 (04) : 1197 - 1209
  • [45] Real-World Treatment Patterns and Transfusion Burden Among Newly Diagnosed Older Adults with Acute Myeloid Leukemia
    Zeidan, Amer M.
    Cheng, Wei-Han
    Kamalakar, Rajesh
    Miller, Catherine
    Bui, Cat N.
    Montez, Melissa
    Yee, Tracy
    Wu, Zheng
    Huntington, Scott F.
    BLOOD, 2022, 140 : 3282 - 3283
  • [46] Frontline Aspacytarabine with Venetoclax for Older/Unfit Patients with Acute Myeloid Leukemia: Preliminary Results of a Phase 1 Study
    Altman, Jessica K.
    Abaza, Yasmin
    Keng, Michael
    Maiti, Abhishek
    Koprivnikar, Jamie
    Tessler, Shoshi
    Blumberg, Chen
    Flaishon, Liat
    Ben Yakar, Ruth
    BLOOD, 2023, 142
  • [47] Real-World Treatment Experience of Venetoclax in Combination with Hypomethylating Agents in Patients with Newly Diagnosed Acute Myeloid Leukemia: Updated Experience from a Predominately Community Setting in the US
    Vachhani, Pankit
    Ma, Esprit
    Xu, Tao
    Montez, Melissa
    Worth, Sarah
    Cheng, Wei-Han
    Werner, Michael
    Abbas, Jonathan
    Donnellan, William
    BLOOD, 2022, 140
  • [48] Real-World Experience of Venetoclax Target Dosing with Concomitant Posaconazole in Adult Patients with Acute Myeloid Leukemia
    Freeman, Tracelyn
    Habib, Alma
    Huang, Ying
    Kumar, Pooja
    Waller, Allyson
    Fleming, Megan
    Mcmillan, Kelsey
    Hartzler, Natalia
    Behbehani, Gregory K.
    Blachly, James S.
    Blaser, Bradley Wayne
    Borate, Uma
    Eisfeld, Ann-Kathrin
    Grieselhuber, Nicole R.
    Larkin, Karilyn T.
    Lee, Shinae
    Long, Meixiao
    Mims, Alice
    Srisuwananukorn, Andrew
    Sahasrabudhe, Kieran
    Koenig, Kristin L.
    BLOOD, 2024, 144 : 2432 - 2433
  • [49] Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers
    Abaza, Yasmin
    Winer, Eric S.
    Murthy, Guru Subramanian Guru
    Shallis, Rory M.
    Matthews, Andrew H.
    Badar, Talha
    Geramita, Emily M.
    Kota, Vamsi K.
    Swaroop, Alok
    Doukas, Peter
    Bradshaw, Danielle
    Helenowski, Irene B.
    Liu, Yingzhe
    Zhang, Hui
    Im, Annie
    Litzow, Mark R.
    Perl, Alexander E.
    Atallah, Ehab
    Altman, Jessica K.
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (04) : 606 - 614
  • [50] Outcomes with molecularly targeted agents as salvage therapy following frontline venetoclax plus hypomethylating agent in adults with acute myeloid leukemia: A multicenter retrospective analysis
    Khanna, Vishesh
    Azenkot, Tali
    Liu, Selina Qiuying
    Gilbert, Jason
    Cheung, Edna
    Lau, Kimberly
    Pollyea, Daniel A.
    Traer, Elie
    Jonas, Brian A.
    Zhang, Tian Y.
    Mannis, Gabriel N.
    LEUKEMIA RESEARCH, 2023, 131
12345